Egis Pharmaceuticals Plc. once again received the Top Employer Hungary certification in 2026, which is the result of an assessment based on an independent, international methodology.

For his outstanding innovation activities, Dr. Balázs Volk, Director of Drug Substance Development at Egis, received the Dennis Gábor Award, while Dr. Pál Fekete, retired Head of Pharmaceutical Technology Operations, was honored with the Dennis Gábor Lifetime Achievement Award. The award serves as a heightened moral recognition for Hungarian professionals who play a creative role in the innovation process and pursue exceptional scientific and R&D activities. Considering all fields of science, only about seven nominated individuals receive this honor each year. The fact that among the awardees we can celebrate both an active and a retired colleague demonstrates the high quality of scientific work and advanced innovation capabilities at Egis.

Egis Pharmaceuticals PLC has inaugarated one of the largest active pharmaceutical ingredient (API) investments in its 112-year history in Budapest. The new HUF 30 billion plant, financed from the company’s own resources, will produce the active ingredient of a globally market-leading medicine, featuring numerous technological innovations.